Pay in 4 interest-free payments of $7.29 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
(Lausanne) 10 , 577 (2019)
Acetate functions as an epigenetic metabolite to promote lipid synthesis under hypoxia
Trikafta/Kaftrio (elexacaftor/tezacaftor/ivacaftor) Disease area(s): Respiratory/rare disease Manufacturer(s): Vertex Pharmaceuticals Incorporated 2024 Sales (USD): $10.24 billion Why it sold so well: Trikafta (marketed as Kaftrio outside the US), a combination therapy of elexacaftor, tezacaftor and ivacaftor, was the primary driver of Vertex Pharmaceuticals strong commercial performance in 2024
ISBN 9781934115220
It has been shown to promote sleep in several species, including rabbits, rats, mice, and humans, with varying effects on REM sleep in cats 1
US$ 26.31
US$ 26.48
US$ 29.31
US$ 29.55
US$ 25.91
US$ 23.94
US$ 23.37
US$ 27.54
US$ 27.32
US$ 28.55
US$ 29.06
US$ 24.43
